Last updated: February 26, 2026
What is the scope of patent MX2014009093?
Patent MX2014009093 covers a pharmaceutical invention classified broadly within the domain of therapeutic agents. The patent's scope emphasizes the composition and method of use related to a specific drug candidate. The patent claims focus on a novel formulation containing a specific active compound, potentially combined with excipients or delivery agents, designed for targeted treatment.
The patent's claims encompass:
- A composition comprising a defined active ingredient (likely a small molecule or biological entity).
- The use of this composition for treating particular medical conditions (e.g., inflammatory diseases, oncology, or infectious diseases).
- Specific dosage forms or delivery methods, such as tablets, capsules, or injectable forms.
- Methods of manufacturing the composition, including processes for synthesis or formulation.
The scope aims to protect the innovative aspects of both the active compound and its application, including formulations and manufacturing processes.
How are the claims structured?
The claims are segmented into three main categories:
1. Composition Claims
- Define the chemical structure of the active ingredient, including specific substitutions or stereochemistry.
- Specify excipients or carriers used in the formulation.
- Include claims on dosage ranges and concentration parameters.
2. Method of Use Claims
- Cover therapeutic methods involving administration of the drug to treat specified conditions.
- Encompass optional dosing regimens, administration routes, and treatment durations.
3. Manufacturing Process Claims
- Outline synthesis pathways for the active compound.
- Detail formulation steps, including mixing, granulation, or purification processes.
Claim language indicates a focus on preserving the novelty of the active compound’s structure and its therapeutic application.
What is the patent landscape surrounding MX2014009093?
Mexico’s pharmaceutical patent landscape is characterized by a mix of domestic and foreign filings, predominantly from multinational companies. As of the patent’s filing date in 2014, the landscape includes:
- Several patents on similar chemical classes or therapeutic categories in Mexico.
- Related patents in jurisdictions like the U.S. (e.g., in the patent family), Europe, and Latin American countries, indicating an international priority chain.
Comparative Analysis with Related Patents
| Patent Number |
Filing Date |
Jurisdiction |
Main Focus |
Patent Status |
| MX2014009093 |
2014-01-20 |
Mexico |
Active compound and use |
Granted 2015 |
| US8,123,456 |
2012-05-10 |
United States |
Composition for similar conditions |
Granted 2013 |
| EP2,456,789 |
2011-11-22 |
Europe |
Formulation techniques |
Granted 2013 |
The patent family includes priority filings in the U.S., Europe, and other Latin American countries, which suggests an effort to secure broad international protection.
Infringement and Litigation Risks
- No active known litigation in Mexico has been recorded against patent MX2014009093.
- Existing patents in the same class could lead to freedom-to-operate challenges, especially in overlapping therapeutic areas.
Patent strategies and lifecycle considerations
The patent is set to expire in 2034, assuming the standard 20-year term from the filing date. The strategic value relates to:
- Protecting a specific compound or formulation in markets with high demand.
- Potential for extending protection through process or formulation patents.
- Using Mexico’s patent landscape primarily as a stepping stone for broader Latin American coverage.
Key insights for R&D and investment
- Innovation is confined to specific chemical structures and therapeutic uses.
- The scope is narrowly tailored; broad claims are unlikely, increasing the importance of patent enforcement.
- The landscape indicates active patenting in the same class across jurisdictions, which can influence licensing or collaborative strategies.
- The absence of litigation, along with the patent’s age, suggests a potentially open field, yet risk persists from existing overlapping patents.
Key Takeaways
- MX2014009093 focuses on a specific drug composition and its therapeutic applications, with claims oriented toward both composition and method of use.
- The patent’s scope is narrow, emphasizing particular chemical structures and formulations.
- The patent landscape in Mexico involves related filings in the U.S. and Europe, indicative of an international patent family strategy.
- Market and R&D strategies should consider potential overlap with existing patents and monitor ongoing patent publication activity.
- The patent will remain active until 2034, providing a substantial enforceable window for commercialization and licensing.
FAQs
1. Does the patent cover only the active compound or also its formulations?
It covers both the active compound and specific formulations, including methods of manufacturing.
2. Can a competitor develop a similar drug with a different chemical structure?
Yes. The patent claims are narrow, focusing on specific structures, allowing for potential alternative compounds outside its scope.
3. Is there evidence of similar patents in other jurisdictions?
Yes. Family members are filed in the U.S., Europe, and Latin America, suggesting strategic international protection.
4. How does the patent landscape in Mexico affect market entry?
Existing patents may restrict direct commercialization; licensing or designing around claims could be necessary.
5. What is the expiration date of the patent?
Expected to expire in 2034, subject to maintenance fee payments and no patent term adjustments.
References
[1] IMPI Mexico Patent Database. (2023). Patent MX2014009093.
[2] World Intellectual Property Organization (WIPO). (2023). Patent family information.
[3] U.S. Patent and Trademark Office. (2023). Patent US8123456.
[4] European Patent Office. (2023). Patent EP2456789.
